MSC Therapies for COVID-19: A Perspective Article
RESTORE partners from the Charité Universitätsmedizin Berlin have published a perspective article in Frontiers in Immunology (Vaccines and Molecular Therapeutics) about the use of mesenchymal stromal/stem cell (MSC) therapies for treating COVID-19.
The RESTORE partners have also been contributing to the intense efforts to curb the devastating spread of SARS-CoV-2 and to treat critically ill patients. We would like to share some of the efforts of the RESTORE partners in targeting and treating SARS-CoV-2/COVID-19. They are involved in a variety of research actions from compassionate treatment and clinical trials of novel therapeutics to identification of novel biomarkers, diagnostics and vaccine development.
Read the press release Download the press release
If you would like to share with RESTORE how you are fighting the virus, please tweet us @RESTOREhorizon
RESTORE Momentum Workshop
Large Scale Research Initiative
RESTORE
The visionary unifying goal of Large Scale Research Initiative RESTORE is to make the transforming promise associated with Advanced Therapies a reality for the benefit of patients and society.
RESTORE sees itself as a “place” where medicine, basic research, technology development and engineering meet, communicate and work together. Through this coordinated, financially strong, academia-industry partnership, we hope to exert a game-changing impact on Europe´s economy and society.
RESTORE
First Advanced Therapies
Science Meeting
25 and 26 November 2019, Berlin
Career corner
Over 200 abstracts received
1ATSM
Registration closure date:
15 November 2019
1ATSM flyer
1ATSM brochure
1ATSM agenda
New material to promote RESTORE available for download:
If you are interested to participate in RESTORE activities JOIN US
RESTORE welcomes the support of all stakeholders who are committed to achieving this goal.
Please support us in our efforts to spread awareness for RESTORE and communicate the work to the scientific community and the general public.